CASI Pharmaceuticals Revenue

Biotechnology Research • 601 Gateway Blvd, San Francisco, United States • 21-50 Employees

CASI Pharmaceuticals revenue & valuation

Annual revenue	$43,200,000
Revenue per employee	$938,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$138,000,000
Total funding	$47,500,000

Key Contacts at CASI Pharmaceuticals

Tom Folinsbee

Independent Director

David Cory

Chief Executive Officer

Jin Xu

Director, Supply And Manufacturing

Susie Zhang

Medical Director

Company overview

Headquarters	601 Gateway Blvd, San Francisco, CA 94080, US
Phone number	+12408642600
Websites	casipharmaceuticals.com casi.cn
NAICS	541714
SIC	283
Keywords	AMR, Immunology, ITP, Autoimmune Disease, Anti-Cd38, Organ Transplant Rejection
Employees	21-50
Socials

CASI Pharmaceuticals Email Formats

CASI Pharmaceuticals uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@casipharmaceuticals.com), used 58.3% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@casipharmaceuticals.com	58.3%
{first initial}{last name}	jdoe@casipharmaceuticals.com	41.6%

About CASI Pharmaceuticals

CASI Pharmaceuticals, Inc. (NASDAQ: CASI), a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with organ transplant rejection and autoimmune diseases, today announced FDA clearance of an IND application for CID-103, an anti-CD38 monoclonal antibody in adults with active and chronic active renal allograft antibody mediated rejection (AMR). The Phase 1 clinical trial is a dose-ranging and safety study evaluating the tolerability and efficacy of CID-103 in patients with AMR.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

C-Suite

Manager

Employees by Department

CASI Pharmaceuticals has 20 employees across 10 departments.

Departments

Number of employees

Funding Data

Explore CASI Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-04-24	14	$32,500,000
2024-07-26	14	$15,000,000

Funding Insights

$47,500,000

Total funding amount

$15,000,000

Most recent funding amount

Number of funding rounds

CASI Pharmaceuticals Tech Stack

Discover the technologies and tools that power CASI Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Layui

UI frameworks

ScrollMagic

JavaScript libraries

Swiper

JavaScript libraries

Microsoft 365

jQuery Migrate

JavaScript libraries

jQuery

JavaScript libraries

Bluehost

Hosting

HSTS

Security

Duda

CMS

Baidu Analytics

Analytics

Nginx

Reverse proxies

Frequently asked questions

CASI Pharmaceuticals is located in 601 Gateway Blvd, San Francisco, US.

You can reach CASI Pharmaceuticals at +12408642600.

CASI Pharmaceuticals generates an estimated annual revenue of $43,107,000. This revenue figure reflects the company's market position and business performance in its industry.

CASI Pharmaceuticals has an estimated valuation of $138,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

CASI Pharmaceuticals has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

CASI Pharmaceuticals has raised a total of $47,500,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at CASI Pharmaceuticals

Tom Folinsbee

Independent Director

David Cory

Chief Executive Officer

Jin Xu

Director, Supply And Manufacturing

Susie Zhang

Medical Director

4.8

40,000 users